Title: Nakamura A, et al. Inhibition of GCN2 sensitizes ASNS-low cancer cells by disrupting the amino acid response. Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7776-E7785.
2183470-13-3
6706-56-5 | N6-Formyl-adenosine | AA01E4XP
877402-45-4 | 3-(Trifluoromethyl)-6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one | AA01E5JW | MFCD24609250
947527-73-3 | VincristineN-Oxide | AA01E5XE
1358575-02-6 | FTBMT - Bio-X | AA01E6JF | MFCD31693831
331005-96-0 | 3-BUTENOIC ACID, 4-(DIMETHYLAMINO)-2-OXO-, METHYL ESTER | AA01E6XV | MFCD24186186
217099-14-4 | Cyclo(-Arg-Gly-Asp-D-Tyr-Lys) trifluoroacetate salt | AA01E72G | MFCD08459533
116330-67-7 | methyl 2-aminohept-6-enoate | AA01E78Q | MFCD25541677
2126160-35-6 | 2-chloro-n-(3-methyl-2-oxobutyl)acetamide | AA01E7BC | MFCD31381374
2126161-55-3 | 2-(2-methoxypyrimidin-4-yl)ethan-1-amine, trifluoroacetic acid | AA01E7EF | MFCD30751462
2094568-66-6 | tert-butyl 5-methoxy-7,7-dimethyl-2,3,6,7-tetrahydro-1H-1,4-diazepine-1-carboxylate | AA01E7HL | MFCD31421109